Market Leadership Psychemedics is the global leader in hair drug testing with FDA 510k approved screens, strong brand recognition among Fortune 500 companies, major police departments, and schools, presenting a prime opportunity to upsell advanced drug detection panels and expanded screening programs to established clients.

Innovation Track Recent launches like Ketamine hair testing and Quartile Reporting demonstrate a commitment to expanding test capabilities and actionable insights, offering cross-sell potential for clients seeking new threat coverage and data-driven decision tools.

AI Driven Insights Quartile Reporting adds analytical depth to drug testing data, enabling customers to benchmark performance and identify trends; this opens doors for enterprise agreements, customized reporting packages, and integration with existing HR analytics platforms.

Financial Growth With reported revenue in the mid six-figure to low seven-figure range and a shrinking year-over-year figure, there is a salesperson’s mandate to accelerate client expansion, renewals, and higher-tier service adoption to stabilize and grow revenue streams.

Strategic Partnerships A diverse client base spanning Fortune 500 firms, government departments, and educational institutions signals opportunities to partner with managed services, compliance, and risk teams, offering bundled solutions, compliance consulting, and volume-based pricing for large-scale deployments.